On 20th September 2024, Impilo, a Nordic healthcare investment firm and KKR, a leading global investment firm, announced the completion of their joint acquisition of Immedica Pharma. Nash Waterman ...

Tevimbra plus chemotherapy was previously approved to treat advanced gastric and gastroesophageal junction cancers. Credit: Orawan Pattarawimonchai/Shutterstock. The ...

Cell therapies are a fundamental aspect of regenerative medicine. Credit: Anusorn Nakdee via Shutterstock. Regenerative medicine, a rapidly advancing field, can be generally defined as a therapeutic ...

* The known adjustments are presented net of their related tax impact, which amount to approximately $1.54 per share. (a) The adjustments include noncash amortization of intangible assets and fair ...

We develop a point of view about the most attractive themes within private markets and seek to collaborate with experienced managers whose unique skills enable them to capitalize on these ...

A Swedish pharma company focused on the commercialization of medicines for rare diseases and specialty care products. Immedica’s capabilities cover marketing and sales, compliance, pharmacovigilance, ...